Skip to main content
HKPD
NASDAQ Trade & Services

Cellyan Biotechnology Files $200M Shelf Registration Amid Nasdaq Delisting Threat

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Negative
Importance info
9
Price
$0.42
Mkt Cap
$4.565M
52W Low
$0.318
52W High
$2.58
52W Position info
32% above low
Off High info
84% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

HKPD sits 32% above its 52-week low of $0.318 on light trading volume (0.2× avg).

Summary

Cellyan Biotechnology filed a universal shelf registration for up to $200 million in securities, a highly dilutive potential offering, as it navigates a Nasdaq delisting threat.


Key Events · Financing and Capital Events · HKPD

  • $200 Million Shelf Registration

    The company registered a universal shelf offering for up to $200,000,000 of Class A ordinary shares, debt securities, warrants, rights, and units. This allows the company to raise capital from time to time.

  • Massive Potential Dilution

    The authorized offering amount of $200 million is a substantial sum, creating the prospect of massive dilution for existing shareholders if fully utilized.

  • Nasdaq Delisting Threat

    This capital raise authorization occurs while the company is non-compliant with Nasdaq's minimum bid price rule, with a deadline of July 13, 2026, to regain compliance.

  • Current Offering Limitations

    The company is currently limited to selling no more than one-third of its public float (approximately $8.3 million) in any 12-month period while its public float remains below $75 million.


Analysis · HKPD · Trade & Services

Cellyan Biotechnology filed a universal shelf registration statement to offer up to $200 million in various securities, including Class A ordinary shares, debt, warrants, rights, and units. This authorization for future capital raises is substantial, indicating a critical need for capital. This filing comes as the company faces a Nasdaq minimum bid price deficiency, with a compliance deadline of July 13, 2026. While current sales are limited to one-third of its public float (approximately $8.3 million), the sheer size of the overall potential offering creates a significant overhang and the prospect of massive dilution for existing shareholders.

How filings like this one have moved

In the 30 days to Sep 13, 2026, 42% of the 419 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HKPD was trading at $0.42 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $4.6M. The 52-week trading range was $0.32 to $2.58. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HKPD - Latest Insights

HKPD
Sep 09, 2026, 8:55 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.1278
Real-time Price: $0.1189 info
Change: -$0.0089 (-7%) info
Market Cap: $1.375M info
HKPD
Aug 07, 2026, 4:30 PM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $0.420
Real-time Price: $0.1189 info
Change: -$0.3011 (-72%) info
Market Cap: $1.375M info
HKPD
Jul 16, 2026, 4:31 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.5374
Real-time Price: $0.1189 info
Change: -$0.4185 (-78%) info
Market Cap: $1.375M info
HKPD
Mar 27, 2026, 3:19 PM EDT
Filing Type: F-1
Importance Score:
9
Price at Filing: $0.690
Real-time Price: $0.1189 info
Change: -$0.5711 (-83%) info
Market Cap: $1.375M info
HKPD
Mar 26, 2026, 7:48 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.620
Real-time Price: $0.1189 info
Change: -$0.5011 (-81%) info
Market Cap: $1.375M info